X-154379314-CGTGACGCGACAACGATTCGGCT-C
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000117.3(EMD):c.-139_-118del variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000211 in 487,802 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 33 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., 3 hem., cov: 26)
Exomes 𝑓: 0.00024 ( 0 hom. 30 hem. )
Consequence
EMD
NM_000117.3 5_prime_UTR
NM_000117.3 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.28
Genes affected
EMD (HGNC:3331): (emerin) Emerin is a serine-rich nuclear membrane protein and a member of the nuclear lamina-associated protein family. It mediates membrane anchorage to the cytoskeleton. Dreifuss-Emery muscular dystrophy is an X-linked inherited degenerative myopathy resulting from mutation in the emerin gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant X-154379314-CGTGACGCGACAACGATTCGGCT-C is Benign according to our data. Variant chrX-154379314-CGTGACGCGACAACGATTCGGCT-C is described in ClinVar as [Likely_benign]. Clinvar id is 1215766.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000114 (13/113626) while in subpopulation EAS AF= 0.000841 (3/3569). AF 95% confidence interval is 0.000228. There are 0 homozygotes in gnomad4. There are 3 alleles in male gnomad4 subpopulation. Median coverage is 26. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EMD | NM_000117.3 | c.-139_-118del | 5_prime_UTR_variant | 1/6 | ENST00000369842.9 | NP_000108.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EMD | ENST00000369842.9 | c.-139_-118del | 5_prime_UTR_variant | 1/6 | 1 | NM_000117.3 | ENSP00000358857 | P1 | ||
EMD | ENST00000369835.3 | c.-139_-118del | 5_prime_UTR_variant | 1/5 | 3 | ENSP00000358850 | ||||
EMD | ENST00000428228.5 | upstream_gene_variant | 3 | ENSP00000401081 | ||||||
EMD | ENST00000486738.5 | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000114 AC: 13AN: 113578Hom.: 0 Cov.: 26 AF XY: 0.0000839 AC XY: 3AN XY: 35760
GnomAD3 genomes
AF:
AC:
13
AN:
113578
Hom.:
Cov.:
26
AF XY:
AC XY:
3
AN XY:
35760
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000241 AC: 90AN: 374176Hom.: 0 AF XY: 0.000263 AC XY: 30AN XY: 114084
GnomAD4 exome
AF:
AC:
90
AN:
374176
Hom.:
AF XY:
AC XY:
30
AN XY:
114084
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000114 AC: 13AN: 113626Hom.: 0 Cov.: 26 AF XY: 0.0000838 AC XY: 3AN XY: 35818
GnomAD4 genome
AF:
AC:
13
AN:
113626
Hom.:
Cov.:
26
AF XY:
AC XY:
3
AN XY:
35818
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 14, 2020 | This variant is associated with the following publications: (PMID: 9536090, 9195226) - |
X-linked Emery-Dreifuss muscular dystrophy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 17, 2022 | - - |
EMD-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 26, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at